| Completed |
: Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
: - Measles
- Rubella
- Mumps
: 2005-08-04
: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine) Other Names:
|
| Completed |
: Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.
: - Measles
- Mumps
- Rubella
: 2013-11-08
: - Biological: MMR Bio-Manguinhos
|
| Completed |
: Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers
: - Japanese Encephalitis
- Measles
- Mumps<
: 2010-08-24
: - Biological: Japanese encephalitis chimeric virus: Measles, mumps, and rubell
|
| Completed |
: Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
: - Measles
- Varicella
- Mumps
: 2008-09-10
: - Biological: PriorixTM Subcutan
|
| Withdrawn |
: Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines
: - Mumps
- Rubella
- Measles
: 2012-11-28
: - Biological: Priorix-Tetra™
|
| Completed |
: Measles, Mumps, and Rubella (MMR) Immunity in College Students
: - Measles
- Mumps
- Rubella
: 2008-05-19
: Biological: MMR vaccine People with no antibodies to either mumps, measles and rubella will be offered t
|
| Completed |
: Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™
: - Mumps
- Rubella
- Measles
: 2006-07-14
: - Biological: MeMuRu-OKA (study vac)
- Biologi
|
| Completed |
: Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine
: - Encephalitis, Japanese
- Measles
- Mumps
: 2016-08-17
: - Biological: CD-JEV Single 0.5
|
| Completed |
: Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)
: - Measles
- Mumps
- Rubella
: 2004-09-22
: Biological: V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks
|
| Completed |
: Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)
: - Measles
- Mumps
- Rubella
: 2012-02-16
: - Biological: MMRV (AMP) Measles
|
